We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 198 results
  1. On Complexity and Emergence: Linking the Hypotheses of Pharmacoresistance in Epilepsy

    Epilepsy is a complex disease mainly defined by the susceptibility to spontaneous recurrent seizures but is also often associated with complex...
    Gabriel Servilha-Menezes, Alan Talevi, Norberto Garcia-Cairasco in Pharmacoresistance in Epilepsy
    Chapter 2023
  2. Pharmacoresistance in Epilepsy From Genes and Molecules to Promising Therapies

    This new edition of Pharmacoresistance in Epilepsy addresses all issues relating to drug-resistance in epilepsy, including studies in patients as...

    Luisa L. Rocha, Alberto Lazarowski, Esper A. Cavalheiro
    Book 2023
  3. Pharmacoresistance in Epilepsy

    Although more than 30 anti-seizure medications are available on the market, epilepsy remains pharmaco-resistant in 30% of patients with focal...
    Daniel San-Juan, Roberto Antonio Cordova Peralta in Pharmacoresistance in Epilepsy
    Chapter 2023
  4. Neonatal Excitotoxicity Triggers Degenerative Processes Related to Seizure Susceptibility and Pharmacoresistance

    Neuronal damage and seizures are two closely related events, not only reciprocally as cause and effect but also through the cellular mechanisms and...
    Mónica E. Ureña-Guerrero, Antoni Camins-Espuny, Carlos Beas-Zárate in Pharmacoresistance in Epilepsy
    Chapter 2023
  5. Cerebrovascular Remodeling and the Role of Vascular Endothelial Growth Factor in the Epileptic Brain and Pharmacoresistance

    The neurovascular unit plays a relevant role in normal situations and pathological conditions involving the nervous system. In epileptic conditions,...
    José Luis Castañeda-Cabral, Mónica E. Ureña-Guerrero, Silvia Josefina López-Pérez in Pharmacoresistance in Epilepsy
    Chapter 2023
  6. GABAergic Neurotransmission Abnormalities in Pharmacoresistant Epilepsy: Experimental and Human Studies

    Despite the fact that there are several drugs available for the treatment of epilepsy, pharmacoresistance remains a major challenge in seizure...
    Sandra Orozco-Suárez, Iris Angélica Feria-Romero, ... Mario A. Alonso-Vanegas in Pharmacoresistance in Epilepsy
    Chapter 2023
  7. The Role of JNK3 in Epilepsy and Neurodegeneration

    N-terminal kinases (JNKs) belong to the subfamily of mitogen-activated protein kinases (MAPKs). JNKs are considered central signal transducers in the...
    Ester Verdaguer, Rubén D. Castro-Torres, ... Carme Auladell in Pharmacoresistance in Epilepsy
    Chapter 2023
  8. Low-frequency Stimulation at the Subiculum Prevents Extensive Secondary Epileptogenesis in Temporal Lobe Epilepsy

    Secondary epileptogenesis is characterized by increased epileptic susceptibility and a tendency to generate epileptiform activities outside the...

    Yujia Shen, Yiwei Gong, ... Cenglin Xu in Neuroscience Bulletin
    Article 20 January 2024
  9. Molecular Mechanisms of Epilepsy: The Role of the Chloride Transporter KCC2

    Epilepsy is a neurological disease characterized by abnormal or synchronous brain activity causing seizures, which may produce convulsions, minor...

    Giorgio Belperio, Claudia Corso, ... Miranda Mele in Journal of Molecular Neuroscience
    Article 12 July 2022
  10. Age-Dependent Phenomena of 6-Hz Corneal Kindling Model in Mice

    Although numerous studies have acknowledged disparities in epilepsy-related disease processes between young and aged animals, little is known about...

    **u Yu, Han Yang, ... Zhenghao Xu in Molecular Neurobiology
    Article 12 January 2024
  11. Role of MicroRNAs in Cell Growth Proliferation and Tumorigenesis

    MicroRNAs (miRNAs) are a type of short noncoding RNA that regulates a broad range of biological processes, including cancer development. MiRNAs have...
    Srilekha Avvari, DKV Prasad, Imran Ali Khan in Role of MicroRNAs in Cancers
    Chapter 2022
  12. Drug-Resistant Epilepsy and the Influence of Age, Gender, and Comorbid Disorders

    In the study of drug-resistant epilepsy (DRE), certain important characteristics remain poorly understood such as the age and gender of patients and...
    Jesús Servando Medel-Matus, César Emmanuel Santana-Gómez, Ángel Alberto Puig-Lagunes in Pharmacoresistance in Epilepsy
    Chapter 2023
  13. Neurobehavioral protective effects of Japanese sake yeast supplement against chronic stress-induced anxiety and depression-like symptoms in mice: Possible role of central adenosine receptors

    Rationale

    Using routine synthetic drugs in the treatment of psychiatric disorders may have some restrictions due to serious side effects and...

    Hooman Bozorgi, Ali Rashidy-Pour, ... Ehsan Motaghi in Psychopharmacology
    Article 23 November 2023
  14. Contribution of the Antiepileptic Drug Administration Regime to Avoid the Development and/or Establishment of Pharmacoresistant Epilepsy

    Although drug-resistant epilepsy has been explained by different mechanisms, the most accepted one involves overexpression of efflux transporters at...
    Pietro Fagiolino, Marta Vázquez in Pharmacoresistance in Epilepsy
    Chapter 2023
  15. Heat Shock Proteins Accelerate the Maturation of Brain Endothelial Cell Glucocorticoid Receptor in Focal Human Drug-Resistant Epilepsy

    Pharmacoresistance in epilepsy is a major challenge to successful clinical therapy. Glucocorticoid receptor (GR) dysregulation can affect the...

    Mohammed Hossain, Sherice Williams, ... Chaitali Ghosh in Molecular Neurobiology
    Article 03 August 2020
  16. GPR120 modulates epileptic seizure and neuroinflammation mediated by NLRP3 inflammasome

    Background

    The complex pathophysiology of epilepsy hampers the development of effective treatments. Although more than ten kinds of anti-seizures...

    Zhang** Qin, Jiaqi Song, ... Weihua Yu in Journal of Neuroinflammation
    Article Open access 27 May 2022
  17. Cortical stimulation in pharmacoresistant focal epilepsies

    Pharmacoresistance and adverse drug events designate a considerable group of patients with focal epilepsies that require alternative treatments such...

    Jens Ellrich in Bioelectronic Medicine
    Article Open access 25 September 2020
  18. mTORC2: The “Ace in the Hole” for a Broader Control of Epileptic Seizures?

    Shuo Zhang, **ongfeng Guo, ... Cenglin Xu in Neuroscience Bulletin
    Article 07 March 2024
  19. On the Development of New Drugs for the Treatment of Drug-Resistant Epilepsy: An Update on Different Approaches to Different Hypotheses

    Despite the continuous expansion of the available pharmacological options for the treatment of epilepsies and remarkable advances in understanding...
    Chapter 2023
Did you find what you were looking for? Share feedback.